|
|
|
|
|
|
|
|
|
|
Previous: INTERMUNE PHARMACEUTICALS INC, S-1, EX-23.1, 2000-09-08 |
Next: INTERMUNE PHARMACEUTICALS INC, S-1, EX-27.2, 2000-09-08 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FINANCIAL
STATEMENTS FOR THE YEAR ENDING DECEMBER 31, 1999 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-START> JAN-01-1999
<PERIOD-END> DEC-31-1999
<CASH> 3,772,110
<SECURITIES> 442,184
<RECEIVABLES> 409,392
<ALLOWANCES> 0
<INVENTORY> 831,145
<CURRENT-ASSETS> 5,577,277
<PP&E> 30,465
<DEPRECIATION> (2,564)
<TOTAL-ASSETS> 5,855,178
<CURRENT-LIABILITIES> 4,354,899
<BONDS> 0
7,773,877
4,506,804
<COMMON> 3,049,664
<OTHER-SE> (15,454,409)
<TOTAL-LIABILITY-AND-EQUITY> 5,855,178
<SALES> 556,401
<TOTAL-REVENUES> 556,401
<CGS> 239,802
<TOTAL-COSTS> 239,802
<OTHER-EXPENSES> 6,580,238
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (185,942)
<INCOME-PRETAX> (6,866,568)
<INCOME-TAX> 0
<INCOME-CONTINUING> (6,866,568)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (6,866,568)
<EPS-BASIC> (8.94)
<EPS-DILUTED> (8.94)
</TABLE>
|
|